Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats

Hepatology

Volumn 29, Issue 1, 1999, Pages 149-160

  Shimizu, Ichiro ^a   Ma, Yue Rong ^b   Mizobuchi, Yoko ^a   Liu, Fei ^c   Miura, Tetsuo ^d   Naka, Yoichiro ^d   Yasuda, Mitugi ^a   Shiba, Masako ^a   Horie, Takahiro ^a   Amagaya, Sakae ^d   Kawada, Norifumi ^e   Hori, Hitoshi ^f   Ito, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d TSUMURA AND CO   (Japan)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; DIMETHYLNITROSAMINE; MALONALDEHYDE; XIAO CHAI HU TANG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HERBAL MEDICINE; LIPID PEROXIDATION; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STELLATE CELL;

ANIMALS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; BLOTTING, WESTERN; CELL DIVISION; CELLS, CULTURED; COLLAGEN; DRUGS, CHINESE HERBAL; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MITOCHONDRIA, LIVER; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; RESPIRATORY BURST; RETINOIDS; SUPEROXIDES;

EID: 0032923588     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290108     Document Type: Article

References (24)

1. Conn HO, Atterbury CE. Cirrhosis. In: Schiff L, Schif ER, eds. Diseases of the Liver. Philadelphia: Lippincott, 1987;725-864.
2. Bissell DM, Roll J. Connective tissue metabolism and hepatic fibrosis. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. 2nd ed. Philadelphia: Saunders, 1990;424-444.
3. Rojkind M, Giambrone MA, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979;76:710-719.
4. Friedman SL. Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis 1990;10:20-29.
5. Gressner AM, Bachem MG. Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin Liver Dis 1990;10:30-46.
6. Goodman DS. Vitamin A metabolism in the liver. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. 2nd ed. New York: Raven Press, 1988;467-474.
7. Hendriks HFJ, Verhoofstad WAMM, Brouwer A, DeLeeuw AM, Knook DL. Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver. Exp Cell Res 1985;160:138-149.
8. Casini A, Ceni E, Salzano R, Milani S, Schuppan D, Surrenti C. Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells. Life Sci 1994;55:1311-1316.
9. Milani S, Herbst H, Schuppan D, Grappone C, Pellegrini G, Pinzani M, Casini A, et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 1994;144:528-537.
10. Iredale JP, Murphy G, Hembry RM, Friedman SL, Arthur MJ. Human hepatic lipocyte synthesize tissue inhibitor of metalloproteinases-1: implicatons for regulation of matrix degradation in liver. J Clin Invest 1992;90:282-287.
11. Lyon BL, Schwarz RI. Ascorbate stimulation of PAT cells causes an increase in transcription rates and a decrease in degradation rates of procollagen mRNA. Nucleic Acids Res 1984;12:2569-2579.
12. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF α and collagen type IIs mediated by oxidative stress through c-myb expression. J Clin Invest 1995;96:2461-2468.
13. Oka H, Fujiwara K, Oda T. Xiao-Chai-Hu-Tang and Gui-Zhi-Fu-Ling-Wan for treatment of chronic hepatitis; recent advances in traditional medicine in east Asia. In: Oda T, Needham J, Otsuka Y, Guo-bin L, eds. Recent Advances in Traditional Medicine in East Asia. Amsterdam: Excerpta Medica, 1984;232-237.
14. Hirayama C, Okumura M, Tanikawa K, Yano M, Mizuta M, Ogawa N. A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis. Gastroenterol Jpn 1989;24:715-719.
15. Tajiri H, Kozaiwa K, Ozaki Y, Harada T, Miki K, Shimizu K, Okada S. The study of the effect of Sho-saiko-to on HbsAg clearance in children with chronic HBV infection and with abnormal liver function test. Acta Paediatr Jpn 1990;94:1811-1815.
16. Gibo Y, Nakamura Y, Takahashi N, Inada H, Nakagawa M, Usuda S, Nakano Y. Clinical study of Sho-saiko-to therapy to the Japanese patients with chronic hepatitis type C (CH-C). Prog Med 1994;14:217-219.
17. Oka H, Yamamoto A, Kuroki T, Harihara S, Marumo T, Kim S-R, Monna T. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995;76:743-749.
18. Fujiwara K, Ohta Y, Ogata I, Oka Y, Hayashi S, Oka H. Treatment trial of traditional oriental medicine in chronic viaral hepatitis. In: Ohta Y, ed. New Trends in Peptic Ulcer and Chronic Hepatitis: Part II. Chronic Hepatitis. Tokyo: Excerpta Medica, 1987;141-146.
19. Shimizu I, Kamamura M, Yao D-F, Nii C, Horie T, Nishikado T, Honda H, et al. Kallikrein-kinin system during the cold pressor test in cirrhotic rats. Int Hepatol Commun 1994;2:170-174.
20. Shiba M, Shimizu I, Yasuda M, li K, Ito S. Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver 1998;18:196-204.
21. Senoo H, Wake K. Suppression of experimental hepatic fibrosis by administration of vitamin A. Lab Invest 1985;52:182-194.
22. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem 1989;264:10756-10762.
23. Gualdi R, Casalgrandi G, Montosi G, Ventura E, Pietrangelo A. Excess iron into hepatocytes is required for activation of collagen type 1 gene during experimental siderosis. Gastroenterology 1994;107:1118-1124.
24. Kawada N, Kuroki T, Kobayashi K, Inoue M, Kaneda K. Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP. Dig Dis Sci 1996;41:1022-1029.